Compare Panacea Biotech with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs SHASUN PHARMA - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH SHASUN PHARMA PANACEA BIOTECH/
SHASUN PHARMA
 
P/E (TTM) x 15.8 123.9 12.8% View Chart
P/BV x 6.2 8.5 72.3% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PANACEA BIOTECH   SHASUN PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
SHASUN PHARMA
Mar-14
PANACEA BIOTECH/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs35494 375.4%   
Low Rs13846 303.1%   
Sales per share (Unadj.) Rs74.6214.2 34.8%  
Earnings per share (Unadj.) Rs6.75.3 125.2%  
Cash flow per share (Unadj.) Rs15.515.8 97.9%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs57.253.3 107.2%  
Shares outstanding (eoy) m61.2556.62 108.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.30.3 1,010.5%   
Avg P/E ratio x36.813.1 281.0%  
P/CF ratio (eoy) x15.94.4 359.2%  
Price / Book Value ratio x4.31.3 328.0%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m15,0613,958 380.6%   
No. of employees `0002.3NA-   
Total wages/salary Rs m1,4712,164 68.0%   
Avg. sales/employee Rs Th1,973.6NM-  
Avg. wages/employee Rs Th635.6NM-  
Avg. net profit/employee Rs Th176.8NM-  
INCOME DATA
Net Sales Rs m4,56712,127 37.7%  
Other income Rs m45229 19.5%   
Total revenues Rs m4,61212,356 37.3%   
Gross profit Rs m2,0301,009 201.1%  
Depreciation Rs m540594 91.0%   
Interest Rs m1,048415 252.5%   
Profit before tax Rs m486230 211.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77-73 -106.0%   
Profit after tax Rs m409302 135.4%  
Gross profit margin %44.48.3 534.1%  
Effective tax rate %15.9-31.7 -50.1%   
Net profit margin %9.02.5 359.6%  
BALANCE SHEET DATA
Current assets Rs m2,4156,884 35.1%   
Current liabilities Rs m9,0778,456 107.3%   
Net working cap to sales %-145.9-13.0 1,125.7%  
Current ratio x0.30.8 32.7%  
Inventory Days Days6562 105.6%  
Debtors Days Days71108 65.9%  
Net fixed assets Rs m8,3334,970 167.7%   
Share capital Rs m61113 54.1%   
"Free" reserves Rs m3,4432,875 119.8%   
Net worth Rs m3,5043,020 116.0%   
Long term debt Rs m4611,817 25.4%   
Total assets Rs m13,75513,347 103.1%  
Interest coverage x1.51.6 94.2%   
Debt to equity ratio x0.10.6 21.9%  
Sales to assets ratio x0.30.9 36.5%   
Return on assets %10.65.4 197.2%  
Return on equity %11.710.0 116.7%  
Return on capital %38.713.3 290.5%  
Exports to sales %20.946.4 45.1%   
Imports to sales %8.114.2 57.2%   
Exports (fob) Rs m9545,622 17.0%   
Imports (cif) Rs m3721,728 21.5%   
Fx inflow Rs m1,2035,843 20.6%   
Fx outflow Rs m4672,173 21.5%   
Net fx Rs m7363,669 20.1%   
CASH FLOW
From Operations Rs m1,049398 263.8%  
From Investments Rs m-54-1,635 3.3%  
From Financial Activity Rs m-1,0111,309 -77.3%  
Net Cashflow Rs m-2071 -27.7%  

Share Holding

Indian Promoters % 74.5 39.2 190.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 3.6 16.7%  
FIIs % 1.3 17.6 7.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 39.6 59.6%  
Shareholders   10,259 20,750 49.4%  
Pledged promoter(s) holding % 35.1 12.3 285.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  DR. DATSONS LABS  GLENMARK PHARMA  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


May 7, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS